PT-141 timeline: what to expect per dose, not per week

PT-141, known as bremelanotide, works differently from most compounds covered in this series. Reports do not generally describe a multi-week adjustment period, since it is used on a per-dose basis for an acute effect rather than something that builds gradually over a course.

Why this is a per-dose timeline, not a weekly one

PT-141 acts on melanocortin receptors involved in sexual arousal pathways in the brain, and its effect is generally reported to be tied to each individual dose rather than accumulating over a multi-week course the way growth-hormone or GLP-1 peptides do.

Onset and duration per dose

Onset is commonly reported within 30 minutes to an hour, with effects described as lasting several hours. Nausea and facial flushing are the most consistently reported side effects, generally described as more noticeable at higher doses.

Common questions

Does tolerance build with repeated use? Some reports describe a reduced response with very frequent use, which is part of why dosing frequency is commonly discussed as a separate question from dose size.

For mechanism, dosing reference and citations, see the PT-141 reference page.